• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
Enantiomeric separation of duloxetine hydrochloride by HPLC using chiral mobile phase additives[J]. Journal of China Pharmaceutical University, 2010, 41(3): 259-262.
Citation: Enantiomeric separation of duloxetine hydrochloride by HPLC using chiral mobile phase additives[J]. Journal of China Pharmaceutical University, 2010, 41(3): 259-262.

Enantiomeric separation of duloxetine hydrochloride by HPLC using chiral mobile phase additives

More Information
  • An HPLC chiral separation method for duloxetine hydrochloride enantiomers using sulphobutylether-β-CD(SBE-β-CD)as chiral mobile phase additive was developed to control the quality of bulk drug.Based on the optimization of the influential factors,including the kind and concentration of chiral additives,the pH of the mobile phase,the ratio of methanol,the HPLC separation was carried out on a Diamonsil C18 column (150 mm×4. 6 mm,5 μm) with a mobile phase of 10 mg/mL SBE-β-CD (pH 2.5,adjusted by phosphoric acid)-methanol(73∶27),the flow rate 1.0 mL/min,the column temperature 40 °C,and the detection wavelength at 230 nm.Under the established chromatographic conditions,duloxetine hydrochloride and its (-)-enantiomer could be separated completely.The standard curve of (-)-enantiomer is linear over the range of 1-50 μg/mL with the correlation coefficient of 0.999 9.The average recovery was 100.8 % (RSD=1.0 %).The resolution of the two enantiomers was up to 2.3 and the limit of quantitation for (-)-enantiomer was 0.02 μg.The method is simple,accurate,specific,and could be used in the quality control of duloxetine hydrochloride.
  • Related Articles

    [1]LOU Bin, WANG Yunshan, GU Minglin, WANG Dawei. Effect of Shouwu Jiangzhi decoction on hyperlipidemia Golden Syrian hamsters based on TNF-α/MAPK/apoB-48 pathway[J]. Journal of China Pharmaceutical University, 2019, 50(6): 728-733. DOI: 10.11665/j.issn.1000-5048.20190614
    [2]ZHANG Yaodan, JIANG Xinyu, CAO Lanjie, WANG Jie, JIANG Cuihua, ZHAO Mengge, ZHANG Jian, YIN Zhiqi. Gypenoside granules improved lipid metabolism in C57BL/6J mice with hyperlipidemia[J]. Journal of China Pharmaceutical University, 2019, 50(6): 713-720. DOI: 10.11665/j.issn.1000-5048.20190612
    [3]XIN Minhang, ZHANG Sanqi. Advances in PI3Kδ selective inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(5): 503-510. DOI: 10.11665/j.issn.1000-5048.20160501
    [4]HUANG Shaoliang, ZHAO Li, GUO Qinglong, WU Yulin. Advances of Hedgehog pathway in tumor resistance[J]. Journal of China Pharmaceutical University, 2016, 47(3): 259-266. DOI: 10.11665/j.issn.1000-5048.20160302
    [5]QI Likai, DI Bin. Advances in research on pharmaceutical impurities[J]. Journal of China Pharmaceutical University, 2015, 46(3): 257-263. DOI: 10.11665/j.issn.1000-5048.20150301
    [6]DENG Danni, TIAN Hong, YAO Wenbing. Advances in therapeutic B-cell vaccines against chronic diseases[J]. Journal of China Pharmaceutical University, 2013, 44(5): 470-475. DOI: 10.11665/j.issn.1000-5048.20130517
    [7]KE Xue. Advances in targeted drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(1): 9-15.
    [8]XU Si-sheng, ZHANG Hui-bin, ZHOU Jin-pei, HUANG Jian-jun. Advances of new antidiabetic drugs[J]. Journal of China Pharmaceutical University, 2011, 42(2): 97-106.
    [9]ZHANG Qi, WANG Guang-ji, DU Yu, XIANG Bing-ren, DENG Hai-shan, A Ji-ye, MA Bo. Application of several pattern recognition methods in metabonomic research of rat hyperlipidemia[J]. Journal of China Pharmaceutical University, 2009, 40(5): 448-454.
    [10]Advances in Selective COX-2 Inhibitors[J]. Journal of China Pharmaceutical University, 2003, (3): 1-6.

Catalog

    Article views (1603) PDF downloads (1979) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return